{
    "nctId": "NCT00917735",
    "briefTitle": "Green Tea and Reduction of Breast Cancer Risk",
    "officialTitle": "Phase II, Randomized,Double-blind, Placebo-controlled, Study of the Efficacy of Green Tea Extract on Biomarkers of Breast Cancer Risk in High Risk Women With Differing Catechol-O-methyl Transferase (COMT) Genotypes",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 1075,
    "primaryOutcomeMeasure": "Mammographic Density",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Signed informed consent\n* Healthy postmenopausal women aged 50-70 years\n* \"Heterogeneously dense\" (51-75% glandular) or \"extremely dense\" (\\>75%glandular) breasts\n* Willing to avoid consumption of green tea for 1 year\n\nExclusion Criteria:\n\n* Positive serological markers of hepatitis B or hepatitis C infections\n* Elevated levels of liver enzymes\n* Recent (within 6 mo) or current hormone or hormone modification therapy, including systemic hormone replacement therapy, SERMS and aromatase inhibitors\n* Current smoker of cigarettes or other tobacco products\n* BMI \\<19 or \\>40 kg/m2\n* Weight change \\> 10 lbs during the previous year\n* History of breast cancer or proliferative breast disease\n* Regular consumption of \\> 7 alcoholic drinks/wk\n* Regular consumption of green tea (\\>1 cup/wk)\n* Recent (within 6 mo) or current use of chemopreventive agents such as tamoxifen, raloxifene or aromatase inhibitors\n* Participation in any weight loss or weight gain studies\n* Currently taking Methotrexate or Enbrel\n* History of ovarian cancer\n* Any form of cancer in the last 5 years\n* Presence of implants",
    "sex": "FEMALE",
    "minimumAge": "50 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}